Trump is also expected to speak about potentially loosening restrictions on marijuana in the U.S. If cannabis is classified ...

Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...

The deal adds some of the biggest names in drug manufacturing to the president's "most favored nation" pricing plan.

President Donald Trump has secured a sweeping set of drug pricing concessions that reach deep into both Medicare and Medicaid ...

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order ...

President Donald Trump sparked health concerns as he addressed the rocketing prices of medicine and drugs in the US.

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

President Donald Trump will be signing an executive order on Thursday that will direct the attorney to “expedite” and “complete” the marijuana rescheduling process, throw a lifeline to the hemp ...

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy that ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Health insurance stocks were jolted last week after U.S. President Donald Trump said he plans to summon executives from the ...

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.